Drug Shortage Report for TEVA-FLUVOXAMINE
Report ID | 40420 |
Drug Identification Number | 02255537 |
Brand name | ACT FLUVOXAMINE |
Common or Proper name | FLUVOXAMINE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FLUVOXAMINE MALEATE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-02-21 |
Estimated end date | 2019-04-30 |
Actual end date | 2019-04-30 |
Shortage status | Resolved |
Updated date | 2019-05-28 |
Company comments | Unable to keep up with demand increase. Was managing inventory and now have depleted all stock. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-05-28 | French | Compare |
v10 | 2019-05-28 | English | Compare |
v9 | 2019-04-11 | French | Compare |
v8 | 2019-04-11 | English | Compare |
v7 | 2019-01-31 | French | Compare |
v6 | 2019-01-31 | English | Compare |
v5 | 2018-10-11 | French | Compare |
v4 | 2018-10-11 | English | Compare |
v3 | 2018-02-22 | English | Compare |
v2 | 2018-02-21 | French | Compare |
v1 | 2018-02-21 | English | Compare |
Showing 1 to 11 of 11